ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Pharmaceutical companies at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
46 pharmaceutical companies are at ACR Convergence 2026 — 133 presentations on the program and 35 with a booth in the exhibit hall. Most represented: Johnson & Johnson (9 on the program), Novartis (9 on the program), Amgen (7 on the program). 41 of them have their own page in this guide. As of Nov 2, 2026.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
A healthcare company with pharmaceutical and medical-device businesses. | Booth Exhibiting at Booth 3228 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Industry Sun Nov 8 12:30pm–1:15pm Managing Active PsA Across Multiple Key Domains: A Clinical Discussion on Axial Involvement Talk Mon Nov 9 9:00am–9:15am Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Novartis East Hanover, NJ | |
A global medicines company developing and marketing prescription treatments. | Booth Exhibiting at Booth 3213 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 5:30pm–7:30pm Turning Complexity Into Clinical Clarity: Practical Approaches for the Comprehensive Assessment of Sjögren's Disease Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Amgen Thousand Oaks, CA | |
Biopharmaceutical company developing and manufacturing medicines for serious diseases. | Booth Exhibiting at Booth 3235 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 10:30am–11:15am UPLIZNA: The First and Only FDA-Approved Treatment for IgG4-RD Talk Mon Nov 9 2:00pm–2:15pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Industry Tue Nov 10 5:30pm–7:30pm Treatment Advances in IgG4-Related Disease: Integrating Targeted Therapy to Improve Patient Outcomes |
AstraZeneca Wilmington, DE | |
Global pharmaceutical company developing and commercializing prescription medicines. | Booth Exhibiting at Booth 3221 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Industry Sun Nov 8 11:30am–12:15pm Systemic Sclerosis: Connecting Clinical Insights, Biology, and Future Research Industry Sun Nov 8 5:30pm–7:30pm Connecting the Evidence: Translational Science, Clinical Trials, and Real-World Data in SLE Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find buyers from pharmaceutical companies
Tell us what you sell and we’ll find the people at these pharmaceutical companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ACR Convergence 2026 by
- Lupus and antiphospholipid syndrome 248
- Rheumatoid arthritis 209
- Epidemiology and outcomes research 209
- Spondyloarthritis and psoriatic arthritis 155
- Basic and translational immunology 145
- Patient care and engagement 140
- Education and careers 137
- Vasculitis 135
- Rare and other inflammatory diseases 125
- Systemic sclerosis and scleroderma 122
- Osteoarthritis and bone 107
- Pediatric rheumatology 82
- Imaging and ultrasound 81
- Myositis and muscle disease 80
- Sjögren’s disease 78
- Treatment safety and immunotherapy 64
- Genetics, genomics and proteomics 48
- Gout and crystal arthritis 45
- Pain and fibromyalgia 40
- Practice management 36
- Infection and rheumatic disease 35
- Pregnancy and reproductive health 33
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction